INHERITED GASTROINTESTINAL CANCERS AND GENETIC TESTING

Access Activity

Overview / Abstract:

This course is designed for gastroenterologists, GI surgeons, medical and surgical oncologists, genetic counselors, geneticists, gynecologists, pathologists, nurse practitioners, physician assistants, cancer registry coordinators, and any other professionals involved in the care of individuals with hereditary cancer syndromes.

This conference will provide an interdisciplinary educational forum to disseminate new knowledge on the identification and management of individuals and families with a genetic susceptibility to the development of gastrointestinal cancers. This conference will describe the clinical presentation, genetic basis, and cancer risks associated with inherited cancer syndromes and integrate familial cancer risk assessment, genetic testing approaches, assessment of actionable of test results, and genetic risk counseling. Didactic and case-based presentations from Columbia University and other experts in the evaluation and management of inherited gastrointestinal cancers syndromes will be featured. The goal is to improve detection of GI cancer syndromes, understand related cancer risks, and optimize strategies for the prevention and early detection of cancers to minimize morbidity and mortality. This course will aid healthcare providers with implementing the best and most current evidence into their routine care for patients and families with inherited GI cancer syndromes.

At the conclusion of this activity, participants will be better able to:

•Identify and diagnose hereditary gastrointestinal syndromes
•Describe the associated cancer risks and surveillance strategies for inheritedgastrointestinal cancer syndromes, including Lynch, polyposis, gastric cancer andfamilial pancreatic adenocarcinoma
•Describe the surgical approaches for the management of inherited gastrointestinalcancer syndromes for treatment and risk reduction
•Present novel approaches to screening and outcomes of cancer surveillance programsin high risk individuals
•Discuss the integration of genetic screening and testing results into clinical care
•Discuss the utility of next generation sequencing technologies through multigenepanel testing and tumor testing
•Describe the impact of multigene panel testing to diagnose and manage inherited GIcancer syndromes
•Recognize the impact of germline genomics on therapeutic options in oncologypractice

Expiration

Apr 17, 2020

Format

Live / Seminar

Cost

$100

Credits / Hours

6.25 AMA PRA Category 1 Credit(s)

Accreditation

ACCME

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

John Chabot, MD Amitabh Chak, MD Daniel C. Chung, MD Armando Del Portillo, MD, PhD Gregory G. Ginsberg, MD Tamas A. Gonda, MD June Hou, MD Chin Hur, MD Bryson W. Katona, MD, PhD P. Ravi Kiran, MD Elana Levinson, MS, MPH, CGC Aimee Lucas, MD Anil K. Rustgi, MD Rachael A. Safyan, MD Beth Schrope, MD Meghna Trivedi, MD Matthew B. Yurgelun, MD

Keywords / Search Terms

Columbia University College of Physicians and Surgeons Live CE CME Seminar CE CME

LIVE Activity Location Details

Date(s)
04-17-2020

The Education and Conference Center of the Vivian and Seymour Milstein Family Heart Center
173 Fort Washington Avenue
New York, NY   10032
United States of America

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map